Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

People with Alopecia Areata have more herpes simplex infections but similar rates of cancer, blood clots, and heart disease compared to those without it.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Four natural compounds were found to promote hair growth effectively.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

An 11-year-old girl with severe hair loss was successfully treated with a new combination therapy.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.